Dermata Therapeutics Inc (DRMA): Next-Year EPS Estimate 31.22%
As of 2026-06-11, Dermata Therapeutics Inc (DRMA) has a next-year EPS growth estimate of 31.22%.
On 2026-05-19, analyst consensus for DRMA's next-year EPS growth shifted from 32.27% to 31.22% — a negative change of 1.05 percentage points. The revised estimate has been sustained across 18 subsequent trading sessions. Current-year growth is projected at 72.92%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 31.22%
- EPS growth this year
- 72.92%
- EPS next quarter (est)
- -$0.55
- Last price
- $1.22
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 31.22% | 72.92% | -$0.55 | $1.22 |
| 2026-06-10 | 31.22% | 72.92% | -$0.55 | $1.19 |
| 2026-06-09 | 31.22% | 72.92% | -$0.55 | $1.20 |
| 2026-06-08 | 31.22% | 72.92% | -$0.55 | $1.21 |
| 2026-06-07 | 31.22% | 72.92% | -$0.55 | $1.18 |
| 2026-06-04 | 31.22% | 72.92% | -$0.55 | $1.25 |
| 2026-06-03 | 31.22% | 72.92% | -$0.55 | $1.27 |
| 2026-06-02 | 31.22% | 72.92% | -$0.55 | $1.36 |
| 2026-06-01 | 31.22% | 72.92% | -$0.55 | $1.34 |
| 2026-05-31 | 31.22% | 72.92% | -$0.55 | $1.30 |
| 2026-05-28 | 31.22% | 72.92% | -$0.55 | $1.35 |
| 2026-05-27 | 31.22% | 72.92% | -$0.55 | $1.30 |
| 2026-05-26 | 31.22% | 72.92% | -$0.55 | $1.23 |
| 2026-05-25 | 31.22% | 72.92% | -$0.55 | $1.26 |
| 2026-05-24 | 31.22% | 72.92% | -$0.55 | $1.26 |
| 2026-05-21 | 31.22% | 72.92% | -$0.55 | $1.24 |
| 2026-05-20 | 31.22% | 72.92% | -$0.55 | $1.25 |
| 2026-05-19 | 31.22% | 72.92% | -$0.55 | $1.18 |
| 2026-05-18 | 32.27% | 73.04% | -$0.57 | $1.20 |
| 2026-05-17 | 32.27% | 73.04% | -$0.57 | $1.19 |
| 2026-05-14 | 32.27% | 73.04% | -$0.53 | $1.23 |
| 2026-05-13 | 32.27% | 73.04% | -$0.53 | $1.23 |
| 2026-05-12 | 32.27% | 73.04% | -$0.53 | $1.24 |
| 2026-05-11 | 32.27% | 73.04% | -$0.53 | $1.22 |
| 2026-05-10 | 32.27% | 73.04% | -$0.53 | $1.26 |
| 2026-05-07 | 32.27% | 73.04% | -$0.53 | $1.30 |
| 2026-05-06 | 32.27% | 73.04% | -$0.53 | $1.27 |
| 2026-05-05 | 32.27% | 73.04% | -$0.53 | $1.30 |
| 2026-05-04 | 32.27% | 73.04% | -$0.53 | $1.30 |
| 2026-05-03 | 32.27% | 73.04% | -$0.53 | $1.33 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Dermata Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Dermata Therapeutics Inc (DRMA) has a next-year EPS growth estimate of 31.22%, based on analyst consensus.
When was the latest EPS estimate revision for DRMA?▾
The most recent revision occurred on 2026-05-19, when analysts adjusted the next-year EPS growth estimate from 32.27% to 31.22%.
What sector and industry does Dermata Therapeutics Inc belong to?▾
Dermata Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. DRMA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Dermata Therapeutics Inc (DRMA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports